| Glenmark USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial |
|---|
| Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial. Glenmark's Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug, Leucovorin Calcium for Injection, 350 mg/vial, of Hospira, Inc. [NDA 008107]. Glenmark will begin distribution in December 2025. |